Search Results 1691-1700 of 18783 for Relapse
... relapsed/refractory (R/R) multiple myeloma (MM) scheduled to receive CAR-T therapy at Mayo Clinic – Rochester. Participation eligibility. Participant ...
Patients must have relapsed or refractory disease AND the following: Cohorts A and B (PTCL cohorts):. patients must have received at least 1 prior line of ...
... relapse or are refractory have a poor prognosis with an estimated survival of 4-6 months. Rigosertib, a Ras mimetic that inhibits the phophoinositide 3 ...
... relapsed despite first-line treatment. Read More on PubMed. Alemtuzumab versus interferon beta 1a as first-line treatment for patients with relapsing ...
... Relapsed or Refractory Diffuse Large B-cell Lymphoma (R/R DLBCL). Rochester ... Relapsed/Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL). A Blood ...
Understanding who is more likely to have a relapse of lymphoma and why. Finding ways to improve quality of life after lymphoma treatment. Publications. See a ...
The purpose of this study is to assess the safety and tolerability of escalating intratumoral doses of mRNA-2752 in participants with relapsed/refractory solid ...
Treatment-naïve or relapsed/refractory CLL patients undergoing CLL antineoplastic treatment. Diagnosis of B-cell CLL established according to International ...
Learn more about this diarrhea-causing infection that often occurs after antibiotic use. Many, but not all, people who get it are in health care facilities.
Cocaine hydrochloride nasal solution is used to numb the mucous membrane inside the nose before a medical procedure or surgery. This medicine is a local ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.